PURPOSE: We evaluated the pathogenicity of the G1961E mutation in the ABCA4 gene, and present the range of retinal phenotypes associated with this mutation in homozygosity in a patient cohort with ABCA4-associated phenotypes. METHODS: Patients were enrolled from the ABCA4 disease database at Columbia University or by inquiry from collaborating physicians. Only patients homozygous for the G1961E mutation were enrolled. The entire ABCA4 gene open reading frame, including all exons and flanking intronic sequences, was sequenced in all patients. Phenotype data were obtained from clinical history and examination, fundus photography, infrared imaging, fundus autofluorescence, fluorescein angiography, and spectral domain-optical coherence tomography. Additional functional data were obtained using the full-field electroretinogram, and static or kinetic perimetry. RESULTS: We evaluated 12 patients homozygous for the G1961E mutation. All patients had evidence of retinal pathology consistent with the range of phenotypes observed in ABCA4 disease. The latest age of onset was recorded at 64 years, in a patient diagnosed initially with age-related macular degeneration (AMD). Of 6 patients in whom severe structural (with/without functional) fundus changes were detected, 5 had additional, heterozygous or homozygous, variants detected in the ABCA4 gene. CONCLUSIONS: Homozygous G1961E mutation in ABCA4 results in a range of retinal pathology. The phenotype usually is at the milder end of the disease spectrum, with severe phenotypes linked to the presence of additional ABCA4 variants. Our report also highlights that milder, late-onset Stargardt disease may be confused with AMD.
PURPOSE: We evaluated the pathogenicity of the G1961E mutation in the ABCA4 gene, and present the range of retinal phenotypes associated with this mutation in homozygosity in a patient cohort with ABCA4-associated phenotypes. METHODS:Patients were enrolled from the ABCA4 disease database at Columbia University or by inquiry from collaborating physicians. Only patients homozygous for the G1961E mutation were enrolled. The entire ABCA4 gene open reading frame, including all exons and flanking intronic sequences, was sequenced in all patients. Phenotype data were obtained from clinical history and examination, fundus photography, infrared imaging, fundus autofluorescence, fluorescein angiography, and spectral domain-optical coherence tomography. Additional functional data were obtained using the full-field electroretinogram, and static or kinetic perimetry. RESULTS: We evaluated 12 patients homozygous for the G1961E mutation. All patients had evidence of retinal pathology consistent with the range of phenotypes observed in ABCA4 disease. The latest age of onset was recorded at 64 years, in a patient diagnosed initially with age-related macular degeneration (AMD). Of 6 patients in whom severe structural (with/without functional) fundus changes were detected, 5 had additional, heterozygous or homozygous, variants detected in the ABCA4 gene. CONCLUSIONS: Homozygous G1961E mutation in ABCA4 results in a range of retinal pathology. The phenotype usually is at the milder end of the disease spectrum, with severe phenotypes linked to the presence of additional ABCA4 variants. Our report also highlights that milder, late-onset Stargardt disease may be confused with AMD.
Authors: A R Webster; E Héon; A J Lotery; K Vandenburgh; T L Casavant; K T Oh; G Beck; G A Fishman; B L Lam; A Levin; J R Heckenlively; S G Jacobson; R G Weleber; V C Sheffield; E M Stone Journal: Invest Ophthalmol Vis Sci Date: 2001-05 Impact factor: 4.799
Authors: F Simonelli; F Testa; G de Crecchio; E Rinaldi; A Hutchinson; A Atkinson; M Dean; M D'Urso; R Allikmets Journal: Invest Ophthalmol Vis Sci Date: 2000-03 Impact factor: 4.799
Authors: R H Guymer; E Héon; A J Lotery; F L Munier; D F Schorderet; P N Baird; R J McNeil; H Haines; V C Sheffield; E M Stone Journal: Arch Ophthalmol Date: 2001-05
Authors: Jana Zernant; Winston Lee; Frederick T Collison; Gerald A Fishman; Yuri V Sergeev; Kaspar Schuerch; Janet R Sparrow; Stephen H Tsang; Rando Allikmets Journal: J Med Genet Date: 2017-04-26 Impact factor: 6.318
Authors: Tobias Duncker; Marcela Marsiglia; Winston Lee; Jana Zernant; Stephen H Tsang; Rando Allikmets; Vivienne C Greenstein; Janet R Sparrow Journal: Invest Ophthalmol Vis Sci Date: 2014-10-23 Impact factor: 4.799
Authors: Pooja Biswas; Jacque L Duncan; Bruno Maranhao; Igor Kozak; Kari Branham; Luis Gabriel; Jonathan H Lin; Giulio Barteselli; Mili Navani; John Suk; Michelle Parke; Catherine Schlechter; Richard G Weleber; John R Heckenlively; Gislin Dagnelie; Pauline Lee; S Amer Riazuddin; Radha Ayyagari Journal: Physiol Genomics Date: 2017-01-27 Impact factor: 3.107
Authors: Tomas R Burke; Tobias Duncker; Russell L Woods; Jonathan P Greenberg; Jana Zernant; Stephen H Tsang; R Theodore Smith; Rando Allikmets; Janet R Sparrow; François C Delori Journal: Invest Ophthalmol Vis Sci Date: 2014-05-01 Impact factor: 4.799
Authors: Jana Zernant; Yajing Angela Xie; Carmen Ayuso; Rosa Riveiro-Alvarez; Miguel-Angel Lopez-Martinez; Francesca Simonelli; Francesco Testa; Michael B Gorin; Samuel P Strom; Mette Bertelsen; Thomas Rosenberg; Philip M Boone; Bo Yuan; Radha Ayyagari; Peter L Nagy; Stephen H Tsang; Peter Gouras; Frederick T Collison; James R Lupski; Gerald A Fishman; Rando Allikmets Journal: Hum Mol Genet Date: 2014-07-31 Impact factor: 6.150
Authors: Tobias Duncker; Stephen H Tsang; Winston Lee; Jana Zernant; Rando Allikmets; François C Delori; Janet R Sparrow Journal: Ophthalmology Date: 2014-10-03 Impact factor: 12.079